Design Therapeutics, Inc. DSGN Q4 2025 Annual earnings
Reported March 9, 2026 · Before market open
Revenue-
EPS-$0.27Beat by $0.11
EPS estimate-$0.38
Next report
Aug 6, 2026 (In 1 week)EPS estimate-$0.36
Financials
Q4 2025Valuation & ratios
Versus estimates
Diluted EPS
Ask the moment Design Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Design Therapeutics, Inc. report Q4 2025 earnings?
- Design Therapeutics, Inc. (DSGN) reported Q4 2025 earnings on March 9, 2026 before market open.
- What were Design Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Design Therapeutics, Inc. reported revenue of - and eps of $-0.27 for Q4 2025.
- Did Design Therapeutics, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.38 by $0.11.
- How did Design Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 12.5% from $-0.24.
- Where can I find Design Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-098474) and the 10-K periodic report (0001193125-26-098491) directly on SEC EDGAR. The filing index links above go to sec.gov.